Skip to main content
Journal cover image

Validating Simple Modifications to the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care.

Publication ,  Journal Article
Goodoory, VC; Riggott, C; Khasawneh, M; Black, CJ; Ford, AC
Published in: Aliment Pharmacol Ther
October 28, 2024

BACKGROUND: The Rome IV criteria for irritable bowel syndrome (IBS) may be too restrictive for clinical practice and research. AIMS: To validate the Rome IV criteria and study the diagnostic performance of simple modifications to them. METHODS: We collected symptom data from consecutive adults with suspected IBS seen in a single clinic. We used a reference standard to confirm IBS (presence of lower abdominal pain associated with altered stool form or frequency; no evidence of organic gastrointestinal disease after limited investigation). We applied Rome IV criteria, but also two modifications. First, we re-incorporated abdominal discomfort but kept symptom frequency required for both abdominal pain and discomfort to at least 1 day per week. Second, we included only abdominal pain but relaxed symptom frequency back to 3 days per month. We calculated sensitivity, specificity and positive and negative likelihood ratios (LRs), with 95% confidence intervals (CIs), for each diagnostic criterion. RESULTS: We recruited 170 patients (76.5% female, mean age 37.9 years). Sensitivity and specificity of the Rome IV criteria were 82.1% and 85.1%, respectively; positive and negative LRs were 5.51 (95% CI 2.95-11.3) and 0.21 (95% CI 0.14-0.31), respectively. Modifying the criteria by relaxing the frequency of abdominal pain to 3 days per month led to the best performance [sensitivity 90.2%, specificity 85.1%, positive LR 6.06 (95% CI 3.25-12.2), and negative LR 0.11 (95% CI 0.07-0.19)]. CONCLUSIONS: The Rome IV criteria performed well in diagnosing IBS. A simple modification relaxing the required frequency of abdominal pain improved their performance.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Aliment Pharmacol Ther

DOI

EISSN

1365-2036

Publication Date

October 28, 2024

Location

England

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3214 Pharmacology and pharmaceutical sciences
  • 3202 Clinical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Goodoory, V. C., Riggott, C., Khasawneh, M., Black, C. J., & Ford, A. C. (2024). Validating Simple Modifications to the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care. Aliment Pharmacol Ther. https://doi.org/10.1111/apt.18363
Goodoory, Vivek C., Christy Riggott, Mais Khasawneh, Christopher J. Black, and Alexander C. Ford. “Validating Simple Modifications to the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care.Aliment Pharmacol Ther, October 28, 2024. https://doi.org/10.1111/apt.18363.
Goodoory VC, Riggott C, Khasawneh M, Black CJ, Ford AC. Validating Simple Modifications to the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care. Aliment Pharmacol Ther. 2024 Oct 28;
Goodoory, Vivek C., et al. “Validating Simple Modifications to the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care.Aliment Pharmacol Ther, Oct. 2024. Pubmed, doi:10.1111/apt.18363.
Goodoory VC, Riggott C, Khasawneh M, Black CJ, Ford AC. Validating Simple Modifications to the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care. Aliment Pharmacol Ther. 2024 Oct 28;
Journal cover image

Published In

Aliment Pharmacol Ther

DOI

EISSN

1365-2036

Publication Date

October 28, 2024

Location

England

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3214 Pharmacology and pharmaceutical sciences
  • 3202 Clinical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 1103 Clinical Sciences